Form 8-K - Current report:
SEC Accession No. 0001193125-25-125860
Filing Date
2025-05-23
Accepted
2025-05-23 16:22:57
Documents
14
Period of Report
2025-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d947753d8k.htm   iXBRL 8-K 25392
2 EX-99.1 d947753dex991.htm EX-99.1 6598
6 GRAPHIC g947753g0522155511842.jpg GRAPHIC 1944
  Complete submission text file 0001193125-25-125860.txt   152648

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20250521.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20250521_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20250521_pre.xml EX-101.PRE 11279
17 EXTRACTED XBRL INSTANCE DOCUMENT d947753d8k_htm.xml XML 3702
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 25982625
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)